Department of General Surgery, Xinhua Hospital, Affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Mol Cell Biochem. 2012 Oct;369(1-2):27-33. doi: 10.1007/s11010-012-1365-0. Epub 2012 Jun 24.
Gallbladder cancer (GBC) is one of the most lethal neoplasm and is the fifth most common malignancy of gastrointestinal tract. The prognosis of gallbladder cancer is extremely terrible partially due to metastasis. Thus, understanding the molecular pathways controlling metastasis of this lethal disease may provide new targets for targeted therapeutic approach. In this study, we investigated the function of nemo-like kinase (NLK) in GBC growth and migration. Lentivirus-mediated siRNA was employed to alleviate the expression level of NLK in GBC cell lines (GBC-SD and SGC-996). Real-time PCR and western-blot analysis demonstrated that both mRNA and protein levels of NLK in GBC-SD and SGC-996 cells were decreased after infection with NLK-siRNA-expressing lentivirus (Lv-shNLK). The proliferation and in vitro tumorigenesis (colony formation) ability as well as migration of GBC-SD and SGC-996 cells with low NLK expression decreased significantly. Our results suggested that NLK is a key regulator involved in proliferation and migration of GBC, and it could be used as a potential therapeutic target for GBC.
胆囊癌(GBC)是最致命的肿瘤之一,是胃肠道第五大常见恶性肿瘤。胆囊癌的预后极差,部分原因是转移。因此,了解控制这种致命疾病转移的分子途径可能为靶向治疗方法提供新的靶点。在这项研究中,我们研究了神经调节蛋白样激酶(NLK)在胆囊癌生长和迁移中的作用。慢病毒介导的 siRNA 用于减轻胆囊癌细胞系(GBC-SD 和 SGC-996)中 NLK 的表达水平。实时 PCR 和 Western blot 分析表明,感染 NLK-siRNA 表达慢病毒(Lv-shNLK)后,GBC-SD 和 SGC-996 细胞中 NLK 的 mRNA 和蛋白水平均降低。低 NLK 表达的 GBC-SD 和 SGC-996 细胞的增殖和体外肿瘤形成(集落形成)能力以及迁移能力显著降低。我们的结果表明,NLK 是参与胆囊癌增殖和迁移的关键调节因子,它可能成为胆囊癌的潜在治疗靶点。